{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:58:22Z","timestamp":1793739502446,"version":"4.6.1"},"reference-count":22,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000659","name":"Research Trainees Coordinating Centre","doi-asserted-by":"publisher","award":["Lectureship provided to MT."],"award-info":[{"award-number":["Lectureship provided to MT."]}],"id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1136\/thoraxjnl-2016-209397","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T02:00:30Z","timestamp":1486173630000},"page":"946-949","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Corticosteroids and infliximab impair the performance of interferon-\u03b3 release assays used for diagnosis of latent tuberculosis"],"prefix":"10.1136","volume":"72","author":[{"given":"Alexander","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond N","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darran","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Elkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-0807","authenticated-orcid":false,"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2016-209397-1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2016-209397-2","doi-asserted-by":"crossref","first-page":"h1060","DOI":"10.1136\/bmj.h1060","article-title":"Screening tests for tuberculosis before starting biological therapy","volume":"350","author":"Hewitt","year":"2015","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2016-209397-3","doi-asserted-by":"crossref","first-page":"e99129","DOI":"10.1371\/journal.pone.0099129","article-title":"Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in Europe","volume":"9","author":"Tebruegge","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.1136\/thoraxjnl-2016-209397-4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/rheumatology\/keq209","article-title":"Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008","volume":"50","author":"Hyrich","year":"2011","journal-title":"Rheumatology"},{"key":"key-10.1136\/thoraxjnl-2016-209397-5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/INF.0000000000000796","article-title":"Diagnostic tests for childhood tuberculosis: past imperfect, present tense and future perfect?","volume":"34","author":"Tebruegge","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/thoraxjnl-2016-209397-6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.1136\/thoraxjnl-2016-209397-7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diagmicrobio.2010.12.020","article-title":"Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon- \u03b3 release assay in patients considered for anti-tumor necrosis factor-\u03b1 therapy","volume":"71","author":"Casas","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.1136\/thoraxjnl-2016-209397-8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.crohns.2012.08.010","article-title":"Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNF\u03b1 therapy","volume":"7","author":"Greveson","year":"2013","journal-title":"J Crohns Colitis"},{"key":"key-10.1136\/thoraxjnl-2016-209397-9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","article-title":"Effect of immunosuppressive therapy on interferon \u03b3 release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"71","author":"Wong","year":"2016","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2016-209397-10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis","volume":"192","author":"Tebruegge","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2016-209397-11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1183\/09031936.00055508","article-title":"Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis","volume":"32","author":"Ruhwald","year":"2008","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2016-209397-12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9394(98)00003-8","article-title":"Dexamethasone concentration in vitreous and serum after oral administration","volume":"125","author":"Weijtens","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/thoraxjnl-2016-209397-13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.10302","article-title":"The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial","volume":"46","author":"St Clair","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key-10.1136\/thoraxjnl-2016-209397-14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jinf.2015.04.004","article-title":"Environmental temperature impacts on the performance of QuantiFERON-TB Gold In-Tube assays","volume":"71","author":"Jarvis","year":"2015","journal-title":"J Infect"},{"key":"key-10.1136\/thoraxjnl-2016-209397-15","unstructured":"Cellestis\/Qiagen. QuantiFERON-TB Gold Package Insert (Doc. No. US05990301L, Version March 2013). http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/2PK\/US.pdf (accessed 8 Dec 2016)."},{"key":"key-10.1136\/thoraxjnl-2016-209397-16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/CDLI.5.4.531-536.1998","article-title":"Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection","volume":"5","author":"Desem","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"key-10.1136\/thoraxjnl-2016-209397-17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tube.2015.02.039","article-title":"The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"key-10.1136\/thoraxjnl-2016-209397-18","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key-10.1136\/thoraxjnl-2016-209397-19","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.4049\/jimmunol.155.7.3322","article-title":"Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets","volume":"155","author":"Brinkmann","year":"1995","journal-title":"J Immunol"},{"key":"key-10.1136\/thoraxjnl-2016-209397-20","doi-asserted-by":"crossref","first-page":"h2226","DOI":"10.1136\/bmj.h2226","article-title":"Limitations of current tuberculosis screening tests in immunosuppressed patients","volume":"350","author":"Clifford","year":"2015","journal-title":"BMJ"},{"key":"key-10.1136\/thoraxjnl-2016-209397-21","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-gamma signaling by glucocorticoids","volume":"170","author":"Hu","year":"2003","journal-title":"J Immunol"},{"key":"key-10.1136\/thoraxjnl-2016-209397-22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","article-title":"Innate immunity to Mycobacterium tuberculosis","volume":"15","author":"van Crevel","year":"2002","journal-title":"Clin Microbiol Rev"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2016-209397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:33:02Z","timestamp":1692671582000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2016-209397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,9,13]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/thoraxjnl-2016-209397"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209397","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}